Clinical Trial Update: Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of Life

View source ↗

Summary

This completed trial evaluates Humira (adalimumab) retention in daily practice for psoriasis and assesses its impact on work productivity and quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Psoriasis | Status: COMPLETED | Results posted: 2016-06-14